Kinaset Therapeutics

Kinaset Therapeutics develops inhaled therapeutics for respiratory diseases.

Health and bio

Latest funding

$103M Series B+ · January 9, 2026

Led by Forge Life Science Partners · Source: fundraisingfox.com

Total raised: $143M across 2 sourced rounds

All 2 rounds ↓

Website: kinasettherapeutics.com.

X: @KinasetT · 83 followers.

LinkedIn: kinaset-tx.

Category: Health and bio.

Sectors: Health Care, Medical, Therapeutics.

Stage: Series B+.

Based in: Boston, United States.

Founded: 2020.

Total raised: $143M in 2 sourced rounds.

Last round: Jan 9, 2026 · 310 days ago.

Headcount: 1–10 employees.

On Recent Funding since: Sep 29, 2026.

Signals

X account@KinasetT · created Nov 19, 2020 (6 years old) · 83 followers

Website registeredMay 1, 2020 (6 years old)

About Kinaset Therapeutics

The company's lead candidate, KN-002, is an anti-inflammatory treatment for severe asthma patients. Kinaset Therapeutics licenses KN-002 and is responsible for its development and commercialization.

TIMELINE · MONEY RAISED

Kinaset Therapeutics | 213 days from website to first raise on record

@KinasetT·Raised $143M in 2 sourced rounds·2 signals before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

Date	Round	Amount	Lead	Source
Jan 9, 2026	Series B+	$103M	FForge Life Science Partners	fundraisingfox.com
Nov 30, 2020	Series A	$40M	55AM Ventures	kinasettherapeutics.com

Timeline

November 19, 2020
X account created
May 1, 2020
Website created

Founders and team

FM
Frazer Morgan Founder

LinkedIn
JM
Jamil M. Beg Founder

LinkedIn
RC
Robert Clarke Founder

LinkedIn
CO
Chris O'Brien Chief Medical Officer

Investors

Companies like Kinaset Therapeutics

PPulmocide$52M Series B+ · Dec 2022
AAltruBio$225M Series B+ · May 2024
SSynthekine$100M Series B+ · Jan 2023
MMozart Therapeutics$25M Series A · Jun 2023
BBionyra$165M Series A · Jun 2026
RRevagenixSeries B+ · Jan 2024

Other companies backed by Forge Life Science Partners

KKhartis Therapeutics$95M Series B+ · Aug 2026
IIDRx$120M Series B+ · Aug 2024
IInfinimmuneSeries A

Forge Life Science Partners portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/kinaset-therapeutics (get a free API key).